Poseida therapeutics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of poseida therapeutics, inc. - pstx

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of poseida therapeutics, inc. (nasdaqgs: pstx) to roche holdings, inc. under the terms of the proposed transaction, shareholders of poseida will receive $9.00 in cash plus a non-tradeable contingent value right to receive certain contingent payments of up to an aggregate of $4.00 per share in cash (upon achieveme.
GM Ratings Summary
Quant
GM Quant Ranking
Sector
Industry
Quant Rating
Quant Score